Trial Details

COMPLETED
Basic Information
Clinical ID c96
Identifier NCT02790281
Trial Title A Study to Investigate Interleukin-6 (IL-6) and IL-6/Soluble IL-6 Receptor (sIL-6R) Complex Levels in Subjects With Active Inflammatory Bowel Disease
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Inflammatory Bowel Disease
Interventions PROCEDURE: Blood sampling
Participant Information
Sponsor Ferring Pharmaceuticals
City Herlev
Country/Region Denmark
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2025-12-14
Primary Completion Date 2025-08-15
Completion Date 2025-08-15